Analysis of the c-myc, K-ras and p53 genes in methylcholanthrene-induced mouse sarcomas

Japanese Journal of Cancer Research

Volumn 90, Issue 1, 1999, Pages 40-47

  Watanabe, Hiroshi ^a,b   Shimokado, Kiyoshi ^a   Asahara, Toshimasa ^a   Dohi, Kiyohiko ^a   Niwa, Ohtsura ^c  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b Sanyou Jin Clinic   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

c myc; K ras; MCA; Mouse sarcoma; p53

Indexed keywords

3 METHYLCHOLANTHRENE; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CODON; EXON; GENE AMPLIFICATION; GENE MUTATION; MOUSE; NONHUMAN; ONCOGENE C MYC; ONCOGENE K RAS; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SARCOMA; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0032968455     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00663.x     Document Type: Article

References (51)

1. Bishop, J. M. The molecular genetics of cancer. Science, 235, 305-310 (1987).
2. Kinzler, K. W. and Vogelstein, B. Lessons from hereditary colorectal cancer. Cell, 87, 159-170 (1996).
3. Field, J. K. and Spandidos, D. A. The role of ras and myc oncogenes in human solid tumours and their relevance in diagnosis and prognosis (review). Anticancer Res., 10, 1-22 (1990).
4. Smith, D. R., Elnatan, J., Myint, T. and Goh, H. S. Association of activated proto-oncogenes ras and myc in colorectal carcinomas. Am. Acad. Med. Singapore, 24, 393-398 (1995).
5. Malkinson, A. M. Primary lung tumors in mice: an experimentally manipulable model of human adenocarcinoma. Cancer Res., 52 (Suppl.), 2670S-2676S (1992).
6. Thompson, T. C., Southgate, J., Kitchener, G. and Land, H. Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ. Cell, 56, 917-930 (1989).
7. Sinn, E., Muller, W., Pattengale, P., Tepler, I., Wallance, R. and Leder, P. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergetic action of oncogenes in vivo. Cell, 49, 465-475 (1987).
8. MacAuley, A. and Pawson, T. Cooperative transforming activities of ras, myc, and src viral oncogenes in noneslablished rat adrenocortical cells. J. Virol., 62, 4712-4721 (1988).
9. Austen, M., Cerni, C., Henriksson, M., Hilfenhaus, S., Luscher-Firzlaff, J. M., Menkel, A., Seelos, C., Sommer, A. and Luscher, B. Regulation of cell growth by the Myc-Max-Mad network: role of Mad proteins and YYI. Curr. Top. Microbiol. Immunol., 224, 123-130 (1997).
10. Harrington, E. A., Fanidi, A. and Evan, G. I. Oncogenes and cell death. Curr. Opin. Genet. Dev., 4, 120-129 (1994).
11. Gazdar, A. F., Carney, D. F., Nau, M. M. and Stehelin, D. Characterization of variant subclasses of cell line derived from small cell lung cancer having distinctive biochemical, morphological and growth properties. Cancer Res., 45, 2924-2930 (1984).
12. Guerin, M., Barrois, M., Terrier, M. J., Spielman, M. and Riou, G. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis. Oncogene Res., 3, 21-31 (1988).
13. Ocadiz, R., Sauceda, R., Cruz, M., Graef, A. M. and Gariglio, P. High correlation between molecular alterations of c-myc oncogene and carcinoma of the uterine cervix. Cancer Res., 47, 4173-4177 (1987).
14. Aisenberg, A. C. Utility of gene rearrangements in lymphoid malignancies. Annu. Rev. Med., 44, 75-84 (1993).
15. Hueber, A. O. and Evan, G. I. Traps to catch unwary oncogenes. Trends Genet., 14, 364-367 (1998).
16. Kauffmann-Zeh, A., Rodriguez-Viciana, P., Ulrich, E., Gilbert, C., Coffer, P., Downward, J. and Evan, G. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature, 385, 544-548 (1997).
17. Grand, R. J. A. and Owens, D. The biochemistry of ras p21. Biochem. J., 279, 609-631 (1991).
18. Gomez, J., Martinez, A. C., Gonzalez, A. and Rebollo, A. Dual role of Ras and Rho proteins: at the cutting edge of life and death. Immunol. Cell. Biol., 76, 125-134 (1998).
19. Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C. C. p53 mutations in human cancers. Science, 253, 49-53 (1991).
20. Levine, A. J., Momand, J. and Finlay, C. A. The p53 tumor suppressor gene. Nature, 351, 453-456 (1991).
21. Greenblatt, M. S., Bennet, W. P., Hollstein, M. and Harris, C. C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878 (1994).
22. Wahl, G. M., Linke, S. P., Paulson, T. G. and Huang, L. C. Maintaining genetic stability through TP53 mediated checkpoint control. Cancer Surv., 29, 183-219 (1997).
23. Niwa, O. and Kominami, R. Lack of allelic preference in amplification and loss of the c-myc oncogene in methylcholanthrene-induced mouse sarcomas. Jpn. J. Cancer Res., 83, 1192-1197 (1992).
24. Niwa, O., Kamiya, K., Furihata, C., Nitta, Y., Wang, Z., Fan, Y.-J., Ninomiya, Y., Kotomura, N. and Kominami, R. Association of minisatellite instability with c-myc gene amplification and K-ras mutation in methylcholanthrene-induced mouse sarcomas. Cancer Res., 55, 5670-5676 (1995).
25. Manam, S. and Nichols, W. Multiple polymerase chain reaction amplification and direct sequencing of homologous sequences: point mutation analysis of the ras genes. Anal. Biochem., 199, 106-111 (1991).
26. Bienz, B., Zakut-Houri, R., Givol, D. and Oren, M. Analysis of the gene coding for the murine cellular tumour antigen p53. EMBO J., 3, 2179-2183 (1984).
27. Shimokado, K., Watanabe, H., Sumii, M., Miyagawa, K., Kamiya, K., Dohi, K. and Niwa, O. p53 gene mutation and loss of heterozygosity of chromosome 11 in methylcholanthrene-induced mouse sarcomas. Jpn. J. Cancer Res., 89, 269-277 (1998).
28. Orita, M., Iwahara, H., Kanasawa, H., Hayashi, K. and Sekiya, T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand comformation polymorphism. Proc. Natl. Acad Sci. USA. 86, 2766-2770 (1989).
29. Tsukiyama, T., Ueda, H., Hirose, S. and Niwa, O. Embryonal long terminal repeat-binding protein is a murine homolog of FTZ-F1, a member of the steroid receptor superfamily. Mol. Cell. Biol., 12, 1286-1291 (1992).
30. Barrios, C., Castresana, J. S., Ruiz, J. and Kreicbergs, A. Amplification of the c-myc proto-oncogenes in soft tissue sarcomas. Oncology, 51, 13-17 (1994).
31. Steiner, P., Rudllph, B., Muller, D. and Eiler, M. The functions of Myc in cell cycle progression and apoptosis. Prog. Cell Cycle Res., 2, 73-82 (1996).
32. Thompson, E. B. The many roles of c-Myc in apoptosis. Annu. Rev. Physiol., 60, 575-600 (1998).
33. Dumenil, D., Neel, H., Lacout, C. and Dautry, F. Infection with a Kirsten-retrovirus can induce a multiplicity of tumorigenic phenotypes in the interleukin-3-dependent FDC-P1 cells. Exp. Hematol., 22, 178-185 (1994).
34. Billudeau, D., Jelinek, D. F., Shah, N., Tucker, W., LeBien, T. W. and Vanness, D. Introduction of an activated N-ras oncogene alters the growth characteristics of the interleukin 6-dependent myeloma cell line ANBL6. Cancer Res., 55, 3640-3646 (1995).
35. Ward, R. L., Todd, A. V., Santiago, F., O'Connor, T. and Hawkins, N. J. Activation of the K-ras oncogene in colorectal neoplasms is associated with decreased apoptosis. Cancer, 79, 1106-1113 (1997).
36. Kinoshita, T., Yokota, T., Arai, K. and Miyajima, A. Regulation of Bcl-2 expression by oncogenic Ras protein in hematopoietic cells. Oncogene, 10, 2207-2212 (1995).
37. Rhim, J. S., Fujita, J. and Park, J. B. Activation of H-ras oncogene in 3-methylcholanthrene-transformed human cell line. Carcinogenesis, 8, 1165-1167 (1987).
38. Carbone, G., Borrello, M. G., Molla, A., Rizzetti, M. G., Pierotti, M. A., DellaPorta, G. and Parmiani, G. Activation of ras oncogenes and expression of tumor-specific transplantation antigens in methylcholanthrene-induced murine fibrosarcomas. Int. J. Cancer, 47, 619-625 (1991).
39. Gressani, K. M., Rollins, L. A., Leone-Kabler, S., Cline, J. M. and Miller, M. S. Induction of mutations in Ki-ras and INK4a in liver tumors of mice exposed in utero to 3-methylcholanthrene. Carcinogenesis, 19, 1045-1052 (1998).
40. Johnson, L., Greenbaum, D., Cichowski, K., Mercer, K., Murphy, E., Schmitt, E., Bronson, R. T., Umanoff, H., Edelmann, W., Kucherlapati, R. and Jacks, T. K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev., 11, 2468-2481 (1997).
41. Leone-Kabler, S., Wessner, L. L., McEntee, M. F., D'Agostino, R. B., Jr. and Miller, M. S. Ki-ras mutations are an early event and correlate with tumor stage in transplacentally-induced murine lung tumors. Carcinogenesis, 18, 1163-1168 (1997).
42. Wang, X. and Witschi, H. Mutations of the Ki-ras protooncogene in 3-methylcholanthrene and urethan-induced and butylated hydroxytoluene-promoted lung tumors of strain A/J and SWR mice. Cancer Lett., 91, 33-39 (1995).
43. Mass, M. J., Jeffers, A. J., Ross, J. A., Nelson, G., Galati, A. J., Stoner, G. D. and Nesnow, S. Ki-ras oncogene mutations in tumors and DNA adducts formed by benz[j]aceanthrylene and benzo[a]pyrene in the lungs of strain A/J mice. Mol. Carcinog., 8, 186-192 (1993).
44. Gressani, K. M., Rollins, L. A., Leone-Kabler, S., Cline, J. M. and Miller, M. S. Induction of mutations in Ki-ras and INK4a in liver tumors of mice exposed in utero to 3-methylcholanthrene. Carcinogenesis, 19, 1045-1052 (1998).
45. Roy, B., Beumon, J., Balint, E. and Reisman, D. Transactivation of the human p53 tumor suppressor gene by c-Myc/ Max contributes to elevated mutant p53 expression in some tumors. Mol. Cell. Biol., 14, 7805-7815 (1994).
46. Livingstone, L. R., White, A., Sprouse, J., Livannos, E., Jacks, T. and Tlsty, T. D. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell, 70, 923-935 (1992).
47. Yin, Y., Tainsky, M. A., Bischoff, F. Z., Strong, L. C. and Wahl, G. M. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell, 70, 937-948 (1992).
48. Castresana, J. S., Barrios, C., Gomez, L. and Kreicbergs, A. No association between c-myc amplification and TP53 mutation in sarcoma tumorigenesis. Cancer Genet. Cytogenet., 76, 47-49 (1994).
49. Imamura, J., Bartram, C. R., Berthold, F., Harms, D., Nakamura, H. and Koeffler, P. Mutation of the p53 gene in neuroblastoma and its relationship with N-myc amplification. Cancer Res., 53, 4053-4058 (1992).
50. Taylor, C. and Mai, S. c-Myc-associated genomic instability of the dihydrofolate reductase locus in vivo. Cancer Detect. Prev., 22, 350-356 (1998).
51. Taylor, C., Jalava, A. and Mai, S. c-Myc dependent initiation of genomic instability during neoplastic transformation. Curr. Top. Microbiol. Immunol., 224, 201-207 (1997).